)
Visual
test
RedHill Biopharma
RedHill Biopharma (RDHL) investor relations material
RedHill Biopharma Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary22 Jan, 2026
Company overview and business model
Specialty biopharmaceutical company focused on GI, infectious diseases, medical countermeasures, and oncology, aiming to become a leading specialty biopharma firm.
Commercializes Talicia® in the U.S. through a joint venture with Cumberland and has out-licensed products for territories outside the U.S.
Pipeline includes five clinical-stage therapeutic candidates, with a focus on in-licensing or acquiring products with high therapeutic and commercial potential.
Plans to commercialize candidates via licensing, partnerships, or independent operations, evaluating co-development and co-promotion on a case-by-case basis.
Financial performance and metrics
Preliminary estimated net revenues for 2025 are $6.5–$7.5 million, down from $8.0 million in 2024.
Estimated cash, cash equivalents, and short-term investments as of December 31, 2025, are approximately $4.1 million.
As of June 30, 2025, pro forma as adjusted total shareholders' equity is $37.4 million, with total capitalization of $37.4 million.
Use of proceeds and capital allocation
No proceeds from the resale of ADSs by the selling shareholder; proceeds from exercise of pre-funded warrants will be used for general corporate purposes.
No current intention to pay cash dividends; earnings will be reinvested in business development and expansion.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- TECH
Flat revenue, margin expansion, and strong pharma/Asia growth amid mixed segment trends. - BV
Revenue up 2.6%-3% to $615M, net loss widens, guidance reaffirmed for 2026. - ENT
Record 2025 revenue and EBITDA, strong cash returns, and robust 2026–2027 outlook. - SANSERA
Q1 FY25 delivered double-digit growth, margin expansion, and a record order book despite global headwinds. - JKHY
Record revenue, margin, and EPS growth drive raised guidance and strong segment momentum. - IEX
Record HST-driven growth and margin gains support 2026 outlook amid industrial headwinds. - KREF
Net loss for 2025, but strong liquidity, portfolio repositioning, and active capital management. - ODFL
Q4 revenue and earnings declined, but yield, service, and capital returns remained strong. - ORN
Acquisition expands marine construction scale and reach, supporting long-term profitable growth. - THG
Record earnings, improved underwriting, and strong capital actions drive robust 2025 results.
Next RedHill Biopharma earnings date
H2 24/258 Apr, 2026
RedHill Biopharma
Next RedHill Biopharma earnings date
H2 24/258 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company focused on the development and commercialization of treatments for gastrointestinal and infectious diseases. The company markets a portfolio of approved products in the United States and is also engaged in clinical development programs targeting conditions such as Crohn’s disease, Helicobacter pylori infection, and COVID-19. RedHill conducts research and commercial activities both independently and through strategic partnerships. The company is headquartered in Tel Aviv, Israel, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage